Morpholino substituted bicyclic pyrimidine urea or carbamate derivatives as mTOR inhibitors
US9242993B2 · kind B2 · utility
1Cited by
2References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 5, 2012 |
| Grant date | Jan 26, 2016 |
| Priority date | — |
| Expiry date | Oct 5, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to compounds of formula (I)wherein m, o, Ra, Rb, R1 and T1 have the meaning as cited in the description and the claims. The compounds are useful as inhibitors of mTOR for the treatment or prophylaxis of mTOR related diseases and disorders. The invention also relates to pharmaceutical compositions including the compounds, the preparation of the compounds as well as their use as medicaments.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.